Sadik Kassim
Chief Tech/Sci/R&D Officer at DANAHER CORPORATION
Network origin in Sadik Kassim first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Tulane University (Louisiana)
135
| College/University | Other Consumer Services | 135 |
| Public Company | Medical Specialties | 41 | |
RA Capital Management LP (Private Equity)
 RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA.
25
| Operating Division | Investment Managers | 25 |
| Public Company | Biotechnology | 10 | |
| Public Company | Pharmaceuticals: Major | 9 | |
| Subsidiary | Biotechnology | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Sadik Kassim via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
RA Capital Management LP
 RA Capital Management LP Investment ManagersFinance RA Capital Management LP (RA Capital) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded by Peter Kolchinsky in 2004. RA Capital provides discretionary investment advisory services to Healthcare Funds and the Nexus Funds which are open only to certain financially sophisticated and high net-worth individuals and entities. | Investment Managers | Chief Executive Officer Portfolio Manager-Equities Portfolio Manager-Equities Analyst-Equity Analyst-Equity Analyst-Equity Analyst-Equity | |
| Massachusetts Institute of Technology | College/University | Director/Board Member Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Doctorate Degree Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
| Georgetown University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Masters Business Admin | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Graduate Degree | |
| VERALTO CORPORATION | Information Technology Services | Chairman Director/Board Member Director/Board Member Director/Board Member | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| FORTIVE CORPORATION | Electronic Equipment/Instruments | Director/Board Member Chairman Director/Board Member Director/Board Member | |
| RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Boston University | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
| SPERO THERAPEUTICS, INC. | Biotechnology | Founder Director/Board Member Director/Board Member | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
Aliada Therapeutics, Inc.
 Aliada Therapeutics, Inc. BiotechnologyHealth Technology Aliada Therapeutics, Inc. is a neuroscience-focused company that aims to overcome the delivery hurdle in large molecule drug development. The company is based in Boston, MA. The company is advancing a generation of CNS therapeutics using its novel BBB crossing platform technology, which can efficiently transport a diverse array of therapeutic cargoes into the brain, resulting in enhanced downstream effectiveness. Aliada Therapeutics was founded by Sanjaya Singh, and the CEO is Adam Rosenberg. | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member | |
Avilar Therapeutics, Inc.
 Avilar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Avilar Therapeutics is an American biopharmaceutical company that specializes in the discovery and development of extracellular protein degraders. The company is based in an undisclosed location. The company has developed a proprietary discovery platform that includes novel, high-affinity, small molecule asgpr ligands and advanced modeling of the biophysics, pharmacokinetics, and pharmacodynamics of atac mediated endocytosis and degradation. Avilar is developing atacs, a new class of protein degraders that shuttle disease-causing proteins from circulation to the endolysosome where the unwanted proteins are degraded. The company is leveraging their atac platform to create a broad and diverse pipeline of first-in-class extracellular protein degraders. The company was founded by Nathaniel Brooks Horwitz and Jamie Kasuboski. The CEO is Daniel S. Grau. | Miscellaneous Commercial Services | Chairman Founder Director/Board Member | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
Superluminal Medicines Inc
 Superluminal Medicines Inc BiotechnologyHealth Technology Superluminal Medicines Inc is a generative biological and chemical company. The company is based in Boston, MA. The CEO of the company is Cony D'Cruz. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member | |
| RESEARCH ALLIANCE CORP. II | Financial Conglomerates | Chief Executive Officer Founder Director of Finance/CFO | |
| A.B. Freeman School of Business | College/University | Corporate Officer/Principal Masters Business Admin Masters Business Admin | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Sionna Therapeutics, Inc.
 Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | Medical/Nursing Services | Director/Board Member Director/Board Member Chief Executive Officer | |
| SYNTHORX, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| WAVE LIFE SCIENCES LTD. | Biotechnology | Director/Board Member Director/Board Member | |
Stylus Medicine, Inc.
 Stylus Medicine, Inc. Medical SpecialtiesHealth Technology Stylus Medicine, Inc. is a company focused on developing innovative solutions to combat diseases using cutting-edge genome engineering and chromatin regulation technologies. Stylus Medicine is based in Boston, MA. The company is backed by RA Ventures and Khosla Ventures. | Medical Specialties | Director/Board Member President | |
Videojet Technologies, Inc.
 Videojet Technologies, Inc. Industrial MachineryProducer Manufacturing Videojet Technologies, Inc. manufactures industrial printers, marking, coding systems, and accessories for the product identification industry. The firm offers ink jets, laser marking products, thermal transfer over printers, case coding and labeling, thermal ink jets, and commercial graphics and addressing products. The company was founded by Albert Blake Dick III in 1969 and is headquartered in Wood Dale, IL. | Industrial Machinery | Corporate Officer/Principal Corporate Officer/Principal | |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | Biotechnology | Director/Board Member Chief Executive Officer | |
| College of the Holy Cross (Massachusetts) | College/University | Undergraduate Degree Undergraduate Degree | |
| ENVISTA HOLDINGS CORPORATION | Medical Specialties | Director/Board Member Investor Relations Contact | |
Nayan Therapeutics, Inc.
 Nayan Therapeutics, Inc. BiotechnologyHealth Technology Nayan Therapeutics, Inc. operates as a biotechnology company. It focuses on small molecule development for oscular disorders involving rod degeneration. The company is headquartered in Medfield, MA. | Biotechnology | Chief Executive Officer Director/Board Member | |
| Harvard T.H. Chan School of Public Health | College/University | Corporate Officer/Principal Graduate Degree | |
IBERIA Capital Partners LLC
 IBERIA Capital Partners LLC Investment Banks/BrokersFinance Founded in 2009, IBERIA Financial Services LLC is a broker/dealer located in Lafayette, Louisiana. The firm is a wholly-owned subsidiary of IBERIABANK Corp. (NasdaqGS: IBKC). The firm offers securities and other financial products to IBERIABANK Corp.'s clients' needs. Through their own subsidiary, Finesco LLC, IBERIA Financial Services offers insurance premium financing to retailers and other commercial customers. | Investment Banks/Brokers | Corporate Officer/Principal Analyst-Equity | |
| Universidad de Los Andes | College/University | Undergraduate Degree Corporate Officer/Principal | |
| The Johns Hopkins University | College/University | Corporate Officer/Principal Doctorate Degree | |
Capital One Securities, Inc.
 Capital One Securities, Inc. Investment Banks/BrokersFinance Founded in 1990, Capital One Southcoast, Inc., formerly Hibernia Southcoast Capital, is a full-service investment banking firm and broker/dealer located in New Orleans, Louisiana with an additional office in Houston, Texas. The firm is a subsidiary of Capital One Financial Corp. (NYSE: COF). They are provide corporate finance, equity research, institutional equity sales and trading services to private and mid-market public companies. The firm offers broad coverage of over 1,000 domestic and foreign institutional accounts for mutual funds, pension funds, hedge funds, insurance firms and other institutional investors. Capital One Southcoast's analysts provide coverage across the energy sector including energy infrastructure, oilfield services and oil & gas exploration and production. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
Jnana Therapeutics, Inc.
 Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | Biotechnology | Founder Director/Board Member | |
KalVista Pharmaceuticals Ltd.
 KalVista Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology KalVista Pharmaceuticals Ltd. develops novel plasma kallikrein inhibitors. It also engages in the development of serine protease inhibitors and novel plasma kallikrein inhibitors represent a, approach to the treatment of DME, a leading cause of adult visual loss, plasma kallikrein inhibitors target a distinct molecular pathway and as such have the potential to offer those patients an effective treatment option. The firm has a clinical and advanced pre-clinical product pipeline targeting both intravitreal injection and oral administration, and its plasma kallikrein inhibitors can be applied to additional indications in ophthalmology. The company was founded by Lloyd Paul Aiello, Andrew Crockett, Robert Haigh and Edward P. Feener in 2011 and is headquartered in Porton Down, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Connecticut | College/University | Undergraduate Degree Doctorate Degree | |
| Business Council of New Orleans & the River Region | Corporate Officer/Principal Chairman | ||
BURKENROAD REPORTS
 BURKENROAD REPORTS Investment Banks/BrokersFinance Burkenroad Reports provides Research. The company was founded by Peter F. Ricchiuti in 1993 and is headquartered in New Orleans, LA. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal | |
Clear Creek Bio, Inc.
 Clear Creek Bio, Inc. Pharmaceuticals: MajorHealth Technology Clear Creek Bio, Inc. engages in the development of therapies that target nucleotide synthesis pathways. The firm focuses on the differentiation blockade in cancer and suppress replication of RNA-based viruses. It uses pharmacodynamic markers to ensure that each patient gets the right drug at the correct dose. The company was founded by David T. Scadden, David B. Sykes, Burt A. Adelman, and Vikram Sheel Kumar in 2017 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Virginia Darden School of Business | College/University | Masters Business Admin Masters Business Admin | |
| ELIEM THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| ALECTOR, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer |
Statistics
International
| United States | 48 |
| Singapore | 2 |
| Colombia | 2 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 21 |
| Consumer Services | 17 |
| Finance | 9 |
| Technology Services | 2 |
| Electronic Technology | 2 |
Operational
| Director/Board Member | 397 |
| Corporate Officer/Principal | 182 |
| Independent Dir/Board Member | 113 |
| Undergraduate Degree | 88 |
| President | 51 |
Most connected contacts
| Insiders | |
|---|---|
| Alan Spoon | 49 |
| Joshua Resnick | 36 |
| Peter Kolchinsky | 32 |
| Elias Zerhouni | 26 |
| Scott Cowen | 26 |
| Risa Stack | 25 |
| Jose-Carlos Gutiérrez-Ramos | 24 |
| María Lorena Gutiérrez Botero | 23 |
| John E. Koerner | 22 |
| Andrew Levin | 21 |
| J. Kent Friedman | 19 |
| David Lubner | 19 |
| Reza Halse | 18 |
| Linda Filler | 17 |
| Derek DiRocco | 17 |
- Stock Market
- Insiders
- Sadik Kassim
- Company connections